UBS AM’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $2.06M | Buy |
|
|||||
|
2025
Q1 | $610K | Buy |
|
|||||
|
2024
Q4 | $676K | Buy |
|
|||||
|
2024
Q3 | $557K | Buy |
|
|||||
|
2024
Q2 | $529K | Buy |
|
|||||
|
2024
Q1 | $619K | Hold |
|
|||||
|
2023
Q4 | $649K | Hold |
|
|||||
|
2023
Q3 | $618K | Buy |
|
|||||
|
2023
Q2 | $325K | Hold |
|
|||||
|
2023
Q1 | $325K | Buy |
|
|||||
|
2022
Q4 | $413K | Sell |
|
|||||
|
2022
Q3 | $945K | Buy |
|
|||||
|
2022
Q2 | $229K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $299K | Buy |
|